ArticleJAMA network open2025

Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity.

Patricia J Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.